What HNL Lab Medicine does

HNL Lab Medicine is a privately-held, multi-regional full-service medical laboratory headquartered in Allentown, Pennsylvania, founded in 1997-1998 and operating for over 28 years. The company provides clinical and anatomic pathology testing, digital pathology, genomics, toxicology, forensic, and surgical pathology services to physician offices, hospitals and health systems, long-term care facilities, employers, and industrial accounts across Pennsylvania. Its operational footprint comprises 50+ Patient Service Centers, 31 acute care laboratories, and a courier logistics network of 129 drivers, processing approximately 5.6 million specimens and delivering 63+ million clinical and anatomic pathology results annually to roughly 3 million patients and 15,000 healthcare providers. The company reports 99% of test results delivered within 24 hours.

The technical platform centers on a digital pathology infrastructure built on Proscia's Concentriq with Leica Biosystems whole-slide imaging hardware, enabling pathologists to work remotely 2-3 days per week (81% pathologist preference over conventional microscopy). In March 2026, HNL deployed Ibex Medical Analytics' AI-powered prostate cancer diagnostics (Ibex Prostate) layered onto this digital workflow, representing its transition from digital to AI-augmented pathology. The wholly-owned HNL Genomics division provides over 3,300 tests across 1,000+ genes spanning Inherited Genetics, Cytogenetics (FISH, chromosome microarray), and Molecular Diagnostics (NGS solid tumor panels of 500+ genes, hematologic malignancy testing, NIPS, and carrier screening). The company holds CAP, CLIA, AABB, and NAME accreditations plus multi-state permits (Pennsylvania, New Jersey, Maryland, New York, California), and has strategic technology partnerships with Roche Diagnostics (preferred IVD partner) and Boomi (enterprise integration).

HNL's business model operates through multiple parallel revenue streams: (1) B2B reference laboratory services billed to providers and health systems under insurance arrangements including Medicare, with dedicated account management and courier specimen pickup; (2) B2C direct-to-consumer testing via the HNL Lab Tests Direct website with credit-card payment; (3) retail walk-in Patient Service Centers with no appointment required; (4) mobile phlebotomy for homebound patients through HNL @Home; and (5) specialty testing in genomics, toxicology, and forensics. The company addresses the structural laboratory workforce shortage through an in-house School of Phlebotomy, Career Connections program, and Student Immersion Program.

Name

HNL Lab Medicine

Legal name

HNL Lab Medicine

Website

https://hnl.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

HNL Lab Medicine is a privately-held, multi-regional full-service medical laboratory headquartered in Allentown, Pennsylvania, providing clinical and anatomic pathology, digital pathology, genomics, and toxicology services to approximately 15,000 healthcare providers and 3 million patients annually across 50+ Patient Service Centers and 31 acute care laboratories.

Ownership category

akta.pro rank

Product category

Clinical and Anatomic Pathology Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industry

Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery) (HLACAMAL)

Keywords

• Clinical laboratory services
• Diagnostic testing services
• Anatomic pathology
• Digital pathology
• Genomic testing

Headquarters

HQ city

Allentown

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services: Clinical and anatomic pathology testing services billed to healthcare providers, hospitals, and health systems under B2B arrangements.
2. Direct-to-Consumer Testing: Patient-ordered laboratory tests through HNL Lab Tests Direct, with credit card payment at time of order.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

HNL Lab Medicine is a multi-regional, full-service medical laboratory that performs clinical and anatomic pathology diagnostic testing for physician offices, hospitals, long-term care facilities, employers, and industrial accounts across Pennsylvania. The company processes approximately 5.6 million specimens annually and delivers over 63 million results across its network of more than 50 Patient Service Centers and 31 acute care laboratories. It offers complementary services including HNL Genomics (inherited genetics, cytogenetics, and molecular diagnostics with 3,300+ tests), Digital Pathology with AI-augmented prostate cancer diagnostics, and direct-to-consumer testing via HNL Lab Tests Direct.

Product overview

HNL Lab Medicine operates as a multi-regional, full-service medical laboratory offering a comprehensive diagnostic testing portfolio. The core offering is its medical laboratory services processing approximately 5.6 million specimens annually across 50+ patient service centers and 31 acute care laboratories in Pennsylvania. The company delivers over 63 million clinical and anatomic pathology results annually. The portfolio includes specialized divisions: HNL Genomics (comprising Inherited Genetics, Cytogenetics, and Molecular Diagnostics with over 3,300 tests covering 1,000+ genes), Digital Pathology Services (AI-augmented with Ibex Prostate integration), and targeted services for hospitals, long-term care, toxicology, forensic pathology, and surgical pathology. Direct-to-consumer access is provided through HNL Lab Tests Direct, while HNL @Home extends services to homebound patients. Educational programs include the School of Phlebotomy, Student Immersion Program, and Career Connections Program.

Differentiator

Problem solved

Functional benefit

Products and services

• HNL Lab Medicine Core Laboratory Services Full-service medical laboratory providing diagnostic testing for physician offices, hospitals, long-term care facilities, employers, and industrial accounts. Processes approximately 5.6 million specimens annually and delivers over 63 million clinical and anatomic pathology results across more than 50 Patient Service Centers and 31 acute care laboratories in Pennsylvania, with 99% of results delivered within 24 hours.
• HNL Lab Tests Direct Direct-to-consumer laboratory testing service allowing patients to order their own lab tests online without a physician order. Offers convenient testing options including lipid panels, pregnancy tests, and STI testing through an e-commerce own-storefront website with credit-card payment at time of order.
• HNL Genomics Comprehensive genetic testing division offering three specialized service areas: Inherited Genetics focused on hereditary disorders, Cytogenetics performing chromosome and FISH analysis, and Molecular Diagnostics covering oncology, cardiology, and prenatal applications. Provides NGS panels covering 500+ genes for solid tumors, FISH panels with 50+ assays, chromosome microarray, Sanger sequencing, carrier screening, and noninvasive prenatal screening (NIPS) expanded to include 22q11.2 deletion syndrome.
• Digital Pathology Services Digital pathology platform enabling pathologists to work remotely and leverage AI-augmented diagnostics. Built on Proscia's Concentriq platform with Leica Biosystems imaging hardware, and includes AI-powered prostate cancer detection via the Ibex Medical Analytics partnership for improved cancer diagnostic accuracy and workflow efficiency.
• Toxicology and Drug Screening Services Forensic toxicology and workplace drug screening services for healthcare providers and employers. CAP-Forensic Drug Testing certified and Pennsylvania Department of Health drug and alcohol testing certified, supporting employer wellness programs and occupational health compliance testing.
• Long-Term Care Laboratory Services Specialized laboratory services for long-term care facilities including nursing homes and assisted living communities, providing convenient specimen collection and testing for extended-care residents with on-site phlebotomy and compliance support.
• Hospitals and Health System Laboratory Services Laboratory services for hospitals and integrated health systems including acute care laboratories, reference testing, and preferred partnership access to Roche Diagnostics in vitro diagnostics solutions for standardized, high-throughput operations across multi-site networks.
• Forensic Pathology Services Forensic pathology services accredited by the National Association of Medical Examiners (NAME), providing autopsy and forensic laboratory services for medical examiner and coroner jurisdictions.
• Surgical Pathology Services Anatomic pathology services for surgical specimens including tissue examination and dermatopathology diagnosis by Board-Certified Dermatopathologists. Supports hospitals and physician practices with biopsy interpretation and cancer diagnostics.
• HNL @Home - Homebound Services At-home laboratory testing services for medically homebound patients, scheduled through healthcare providers. Includes mobile phlebotomy for specimen collection at patient residences, expanding HNL's reach beyond Patient Service Centers.
• Noninvasive Prenatal Screening (NIPS) Advanced prenatal screening using cell-free DNA analysis from maternal blood, expanded to include 22q11.2 deletion syndrome screening alongside standard aneuploidy screening. Part of the HNL Genomics prenatal testing portfolio.
• Molecular Oncology Testing Molecular diagnostic testing for cancer including a solid tumor NGS panel analyzing 500+ genes with results in 14 days, cytogenetics FISH panels with 50+ assays, and hematologic malignancy testing as part of HNL Genomics' Molecular Diagnostics service line.

Quantifiable outcome

• 99% of laboratory test results delivered within 24 hours
• +4 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Roche DiagnosticscoreStrategic or Co-development Partner · 7 April 2026Preferred partnership to improve laboratory performance, speed, and accuracy of diagnostic results across HNL's multi-regional network in Pennsylvania. Leverages Roche's in vitro diagnostics solutions, which are involved in approximately 70% of healthcare decisions. The collaboration aims to maximize staff efficiency, reduce turnaround times, and standardize operations through shared innovation and operational goals.
• Ibex Medical AnalyticscoreTechnology or Integration · 19 March 2026Partnership to deploy AI-powered prostate cancer diagnostics (Ibex Prostate) for both biopsies and transurethral resection of the prostate procedures. The AI layer integrates into HNL's existing digital pathology infrastructure built on Proscia's Concentriq platform and Leica Biosystems imaging hardware. Marks HNL's transition from digital to AI-augmented pathology practice for enhanced cancer detection accuracy and workflow efficiency.

Scale indicators8 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• ARUP Laboratories: Academic/clinical reference laboratory affiliated with University of Utah Health; offers esoteric testing, anatomic pathology, and digital pathology. Comparable to HNL on esoteric reference testing and integrated hospital academic partnerships.
• Laboratory Corporation of America (Labcorp): Second-largest US clinical reference laboratory, with hospital lab management services, specialty/genomic testing (Labcorp Drug Development, Invitae, etc.), and a national PSC network. Direct competitor to HNL's full-service medical laboratory, hospital partnership, and genomics offerings.
• Sonic Healthcare USA: US arm of Sonic Healthcare operating multi-regional clinical laboratories via subsidiaries (e.g., ProPath, East Side Clinical Labs, Clinical Pathology Laboratories). Closest pure-play analogue to HNL as a multi-regional full-service medical laboratory with reference testing, anatomic pathology, and hospital lab partnerships.
• BioReference Laboratories: Multi-specialty reference laboratory with strong women's health, oncology, and urology menus plus hospital outreach. Leadership overlap with HNL (former BioReference COO Warren Erdmann is now HNL COO); provides a directly comparable specialty reference lab model.
• Quest Diagnostics: Largest US clinical reference laboratory. Directly comparable to HNL Lab Medicine as a full-service clinical lab serving physicians, hospitals, and consumers nationally, with overlapping menus including routine chemistry, immunoassays, and molecular/genomic specialty testing. National incumbent against which HNL competes in Pennsylvania.

Regional players

• NorDx (MaineHealth): Regional clinical laboratory serving MaineHealth and northern New England; comparable multi-regional full-service medical laboratory with hospital outreach model. HNL VP Becky Simmons formerly served as NorDx COO, making this a strong operational analogue.
• Geisinger Medical Laboratories: Regional laboratory arm of Geisinger Health serving central and northeastern Pennsylvania. Direct geographic overlap and comparable regional full-service medical laboratory, with HNL leadership alumni from Geisinger's clinical pathology informatics division.

Broad incumbents

• Eurofins Clinical Diagnostics: Global clinical diagnostics network with US operations (including Viracor, Boston Heart, Eurofins Genomics). Comparable to HNL on full-service clinical, specialty, and genomic testing across multiple modalities, but as a much larger incumbent in a broader portfolio.

Emerging players

• NeoGenomics: Oncology-focused clinical laboratory with molecular and anatomic pathology offerings. Comparable to HNL's HNL Genomics division on NGS solid tumor panels, hematologic malignancy testing, and oncology workflow via digital pathology.
• PerkinElmer Genomics (Revvity): Genomic and reproductive health testing services including NIPS and rare disease panels. Comparable to HNL's HNL Genomics division on NIPS, inherited genetics, cytogenetics, and molecular diagnostics services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/HNLLabMedicine
• LinkedInlinkedin.com/company/hnl-lab-medicine
• Xx.com/HNL_LabMedicine

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HNL Lab Medicine